Probability of Success in Drug Development

Piet H van der Graaf^{1

2}

Affiliations

Editorial

Piet H van der Graaf. Clin Pharmacol Ther. 2022 May.

. 2022 May;111(5):983-985.

doi: 10.1002/cpt.2568.

Piet H van der Graaf^{1

2}

No abstract available

Comment on

A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials.
Hampson LV, Holzhauer B, Bornkamp B, Kahn J, Lange MR, Luo WL, Singh P, Ballerstedt S, Cioppa GD. Hampson LV, et al. Clin Pharmacol Ther. 2022 May;111(5):1050-1060. doi: 10.1002/cpt.2488. Epub 2021 Dec 13. Clin Pharmacol Ther. 2022. PMID: 34762298 Review.

1. Hampson, L.V. et al. A new comprehensive approach to assess the probability of success of development programs before pivotal trials. Clin. Pharmacol. Ther. 111, 1050-1060 (2022).
1. Lalonde, R.L. & Peck, C.C. Probability of success: a crucial concept to inform decision making in pharmaceutical research and development. Clin. Pharmacol. Ther. 111, 1001-1003 (2022).
1. Fernando, K. et al. Achieving end-to-end success in the clinic: Pfizer's learnings on R&D productivity. Drug Discov. Today. 27, 697-704 (2022).
1. Wu, S.S., Fernando, K., Allerton, C., Jansen, K.U., Vincent, M.S. & Dolsten, M. Reviving an R&D pipeline: a step change in the Phase II success rate. Drug Discov. Today 26, 308-314 (2021).
1. Peck, R.W., Holstein, S.A. & van der Graaf, P.H. BIA 10-2474: some lessons are clear but important questions remain unanswered. Clin. Pharmacol. Ther. 111, 343-345 (2022).